High Performance Fetal/Maternal Monitor
ISSAQUAH, Wash.--(BUSINESS WIRE)-- Spacelabs Healthcare, a pioneer of patient monitoring & connectivity solutions, today announced the introduction of the Sonicaid Encore, a high performance fetal and maternal monitor that uses today’s most advanced technology for patient monitoring in labor and delivery.
“The labor and delivery environment can be stressful and situations can change rapidly,” said Nicholas Ong, President of Spacelabs Healthcare. “The Encore monitor delivers the high performance needed to provide continuous, reliable monitoring of both mother and fetus.”
Encore uses today’s most advanced ultrasound technology to enable clinicians to quickly and easily locate and track the fetal heartbeat, minimizing the need for direct fetal ECG monitoring. Further, the advanced design and high sensitivity of the toco transducer enable uterine activity monitoring for patients of all sizes, including those with high BMI, minimizing the need for intrauterine pressure monitoring.
As with other Spacelabs monitors Encore provides excellent connectivity. Both serial and LAN interfaces are available for most central recording and obstetrical data management systems.
About Spacelabs Healthcare, Inc.
Spacelabs Healthcare, Inc.(www.spacelabshealthcare.com), a wholly-owned subsidiary of OSI Systems, Inc., is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. The Company has offices in the United States, United Kingdom, Canada, France, Germany, Italy, China, India and Singapore and distribution partners in more than 100 countries around the world.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company’s expectations, goals or intentions about the future, including, but not limited to, statements regarding the performance of the Company’s Encore fetal/maternal monitor. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.
Ross Garland, 425-657-7200 x4000
KEYWORDS: United States North America Washington
INDUSTRY KEYWORDS: Technology Hardware Health Hospitals Medical Devices General Health